View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . December 29th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Pharmacology - NicOx' Naproxcinod Shows Differentiated 24-Hour Blood Pressure Profile After 13 Weeks Treatment

Angiosarcoma - Research on angiosarcoma reported by N. Penel et al

Breast Cancer - Studies from J.R. Garbay et al have provided new data on breast cancer

Cancer - Research on cancer described by scientists at National Cancer Institute

Clinical Trial Research - Reports by Z. Waibler and co-researchers describe recent advances in clinical trial research

Head and Neck Cancer - Research on substance abuse treatment published by scientists at University of California, Medical Department

Hepatocellular Cancer - New hepatocellular cancer research reported from University of Texas

Hypereosinophilic Syndrome - Research from University of Heidelberg reveals new findings on hypereosinophilic syndrome

Life Sciences - Investigators at Semmelweis University have published new data on life sciences

Life Sciences - Researchers at University of Auckland have published new data on life sciences

Lymphoma - Reports from A. Cashen and co-researchers add new data to research in lymphoma

Monoclonal Antibodies - Researchers from University of Pennsylvania detail findings in monoclonal antibodies

Non-Small Cell Lung Cancer - Studies from University of Texas reveal new findings on non-small cell lung cancer

Prostate Cancer - Study results from University of California broaden understanding of prostate cancer

Psoriasis - Findings from A.N. Geria and co-authors provide new insights into psoriasis

Solid Cancer - Ruhr University publishes research in solid cancer

Vaccines - Data on vaccines described by J.H. Mcarthur et al

Vomiting - Study results from A. Fabi and colleagues broaden understanding of vomiting

Colon Cancer Therapy - Studies from University Hospital add new findings in the area of colon cancer therapy

Life Sciences - New life sciences research from University of Torino described

Pharmacokinetics - Research from S. Rohatagi and co-researchers in the area of pharmacokinetics described

Surgery - Study findings from University of Pennsylvania broaden understanding of surgery

Acute Myeloid Leukemia - Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia

American Society for Cell Biology - In just 5 years, gene discovery to clinical trial of potential treatment

Arete Therapeutics Inc. - Arete Therapeutics Reports Positive Phase I Data for AR9281

Asthma - Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma

Cancer - Oncothyreon announces development plans and personnel changes and updates financial guidance

Cancer Vaccines - MabVax Therapeutics Receives Two Small Business Technology Transfer Program Awards From the National Cancer Institute

Cancer Vaccines - Merck KGaA acquires manufacturing rights for Stimuvax from Oncothyreon

Clinical Trial Research - MannKind Reports Top-Line Results from Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes

Drug Delivery - AAIPharma and CORTRIA Corporation Sign Drug Delivery Deal

Enzyme Research - EntreMed Focuses on Development of ENMD-2076

Gene Therapy - CRSTI and Medical City Hospital Dallas Currently Recruiting for a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure

Georgetown University Medical Center - Planned safety analysis of a breast cancer prevention study reveals encouraging news for exemestane

Glioblastoma - Pfizer and Celldex Therapeutics Announce Amendment to ACT III Study of CDX-110 in Glioblastoma Multiforme

HIV/AIDS Cancer - PTC Therapeutics Initiates Two Clinical Trials of PTC299 in Cancer Patients

Hypertension - NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis

Knee Replacement - Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

MannKind Corporation - MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes

Merck & Co., Inc. - Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS® raltegravir in Adult Patients Previously Untreated for HIV-1

Multiple Sclerosis - Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis

Neuroendocrine Cancer - Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors

Osteoarthritis - CrystalGenomics Announces Positive Phase IIa Results for Osteoarthritis Study of CG100649

Pharmacokinetics - PolyMedix Announces Positive Phase I Clinical Data with PMX-30063 Novel Antibiotic Drug Candidate

Prostate Cancer - Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

Psoriasis - Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

Stem Cell Research - Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke

Thrombocytopenia - TWO PRALATREXATE STUDIES PRESENTED AT THE 50th ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY

Type 2 Diabetes - Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx